GLENMARK LIFE SCIENCES
Back to Cashflow Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹414 Cr | ₹306 Cr | ₹598 Cr | ₹388 Cr | ₹195 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK LIFE SCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹414 Cr |
Mar2023 | ₹306 Cr |
Mar2022 | ₹598 Cr |
Mar2021 | ₹388 Cr |
Mar2020 | ₹195 Cr |
How is Cash Flow from Operating Activities of GLENMARK LIFE SCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹414 Cr | 35.13 | |
Mar2023 | ₹306 Cr | -48.79 | |
Mar2022 | ₹598 Cr | 53.97 | |
Mar2021 | ₹388 Cr | 99.03 | |
Mar2020 | ₹195 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹12,849.0 Cr | -2.9% | 0.4% | 72.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -2.9% |
0.4% |
72.6% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses